Tse Hui Lim

Whole-Genome and Epigenomic Landscapes of Etiologically Distinct Subtypes of Cholangiocarcinoma

Apinya Jusakul, Ioana Cutcutache, Chern Han Yong et al. · Cancer Discovery · 2017 · 989 citations · Full text

Medicine, Genetics, Oncology +17

Chromosome 1q21.3 amplification is a trackable biomarker and actionable target for breast cancer recurrence

Jian Yuan Goh, Min Feng, Wenyu Wang et al. · Nature Medicine · 2017 · 158 citations

Life Sciences, Genetics, Oncology +13

Utility of incorporating next-generation sequencing (NGS) in an Asian non-small cell lung cancer (NSCLC) population: Incremental yield of actionable alterations and cost-effectiveness analysis

Aaron C. Tan, Gillianne Lai, Gek San Tan et al. · Lung Cancer · 2019 · 124 citations

Medicine, Oncology, Pharmacoeconomics +17

Clonal <i>MET</i> Amplification as a Determinant of Tyrosine Kinase Inhibitor Resistance in Epidermal Growth Factor Receptor–Mutant Non–Small-Cell Lung Cancer

Gillianne Lai, Tse Hui Lim, John Lim et al. · Journal of Clinical Oncology · 2019 · 117 citations

Medicine, Cancer Biology, Oncology +17

Clear cell sarcomas of the kidney are characterised by <i><scp>BCOR</scp></i> gene abnormalities, including exon 15 internal tandem duplications and <i><scp>BCOR</scp>–<scp>CCNB</scp>3</i> gene fusion

M. K. Wong, Cedric Chuan Young Ng, Chik Hong Kuick et al. · Histopathology · 2017 · 75 citations · Full text

Medicine, Oncology, Pathology +16